Needle Nerve Contact in Ultrasound Guided Femoral Block
Last updated on July 2021Recruitment
- Recruitment Status
- Unknown status
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Peripheral Nerve Injury
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Outcomes Assessor)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Fourty-four patients with hip fracture (American Society of Anesthesiologists physical status 1-3) are being randomized to receive the femoral block with an out-of-plane (needle inserted at a 45°-60° angle 1 cm caudal to the midpoint of the ultrasound probe just above the femoral nerve) or an in-pla...
Fourty-four patients with hip fracture (American Society of Anesthesiologists physical status 1-3) are being randomized to receive the femoral block with an out-of-plane (needle inserted at a 45°-60° angle 1 cm caudal to the midpoint of the ultrasound probe just above the femoral nerve) or an in-plane technique (needle inserted 0.5 cm from the side of the probe lateral to the femoral nerve). The data collected includes the depth of needle insertion at the endpoint before injection, response to nerve stimulation, distribution of the injected volume in relation to the nerve (anterior vs posterior, the latter indicating impalement), block efficacy at 20 minutes and 24 hours, and any signs of nerve injury).
Tracking Information
- NCT #
- NCT01554722
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Xavier Sala-Blanch, MD University Clinic Barcelona Principal Investigator: Ana Ruiz, MD University of Barcelona Study Chair: Julia Martinez-Ocon, MD University of Barcelona Study Chair: Maria J Carretero, MD University of Barcelona Study Chair: Gerard Sánchez-Etayo, MD University of Barcelona Study Director: Admir Hadzic, Prof Dr Columbia University St Luke's Hospital
Get Well Soon